Somagenetix
https://www.wysszurich.ch/projects/somagenetix
8952 Schlieren, Wagistrasse 23
Gene therapy solutions for patients with severe inherited diseases.
Somagenetix
Wagistrasse 23
8952 Schlieren
440 Ergebnisse für "acting" unter Somagenetix
UZH - UZH Journal - Thinking and Acting
... Thinking and Acting German Literature: Theory – Analysis – Transfer A complementary minor study ... UZH - UZH Journal - Thinking and Acting ... UZH - UZH Journal - Thinking and Acting Home Main navigation Search Jump to content Breadcrumb ... UZH - UZH Journal - Thinking and Acting ...
Severe phenotype with cis-acting heterozygous PMP22 mutations - Zur...
... Severe phenotype with cis- acting heterozygous PMP22 mutations Copy Abstract We report on a 20-year ... Severe phenotype with cis- acting heterozygous PMP22 mutations - Zurich Open Repository and Archive ... Severe phenotype with cis- acting heterozygous PMP22 mutations - Zurich Open Repository and Archive ... Severe phenotype with cis- acting heterozygous PMP22 mutations - Zurich Open Repository and Archive ...
University of Zurich
https://www.campus-schlieren.uzh.ch/en.html
8952 Schlieren, Wagistrasse 12
The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.
University of Zurich
Wagistrasse 12
8952 Schlieren
296 Ergebnisse für "acting" unter University of Zurich
Generation and characterization of Anti-VGLUT nanobodies acting as ...
... Generation and characterization of Anti-VGLUT nanobodies acting as inhibitors of transport - Zurich ... Generation and characterization of Anti-VGLUT nanobodies acting as inhibitors of transport - Zurich ... Generation and characterization of Anti-VGLUT nanobodies acting as inhibitors of transport - Zurich ...
Strategic control of gastrointestinal nematodes in grazing sheep wi...
... efficacy of a long- acting moxidectin formulation (Cydectin® 2% LA) against gastrointestinal nematodes (GIN ... - acting moxidectin formulation (Cydectin® 2% LA) against gastrointestinal nematodes (GIN). Naturally ... Strategic control of gastrointestinal nematodes in grazing sheep with a long- acting moxidectin ... Strategic control of gastrointestinal nematodes in grazing sheep with a long- acting moxidectin ... Strategic control of gastrointestinal nematodes in grazing sheep with a long- acting moxidectin ...
Topadur Pharma AG
8952 Schlieren, Grabenstrasse 11a
A team dedicated to develop innovative speciality medication for the treatment of severe wound-healing problems enabling significant improvements of patients quality of life. TOPADUR’s lead R&D programs are local active, highly potent, dual mode of action drugs. TOPADUR’s unique development candidates #3;work on validated drug targets resulting in higher than average clinical success chances.
Topadur Pharma AG
Grabenstrasse 11a
8952 Schlieren
8 Ergebnisse für "acting" unter Topadur Pharma AG
Topadur Pharma
... the manuscript entitled “A dual- acting nitric oxide donor and phosphodiesterase 5 inhibitor promotes ... . Therefore, we designed and synthesized a compound with a unique dual- acting activity (TOP-N53), acting as a ... manuscript entitled “A dual- acting nitric oxide donor and phosphodiesterase 5 inhibitor promotes wound ... . Therefore, we designed and synthesized a compound with a unique dual- acting activity (TOP-N53), acting as a ...
Topadur Pharma
... unsuccessful implantation on the hairy scalp. Here, it is suggested that TOP-M119 (M119), a novel drug acting ... versican. A Dual- Acting Nitric Oxide Donor and Phosphodiesterase 5 Inhibitor Promotes Wound Healing in ... unsuccessful implantation on the hairy scalp. Here, it is suggested that TOP-M119 (M119), a novel drug acting ... the Journal of Investigative Dermatology A Dual- Acting Nitric Oxide Donor and Phosphodiesterase 5 ...
University Hospital Zurich, Research and Education Office
https://www.usz.ch/forschung/Seiten/default.aspx
8091 Zürich, Rämistrasse 100
The University Hospital Zurich is one of Switzerland’s largest hospitals and a pioneering institution in the field of clinical research. In its 40 departments and institutes, it assembles and practices all medical disciplines and enjoys an excellent reputation for state-of-the-art medicine, professional and com- passionate patient care, and groundbreaking bench-to-bedside translational medical research.
University Hospital Zurich, Research and Education Office
Rämistrasse 100
8091 Zürich
32 Ergebnisse für "acting" unter University Hospital Zurich, Research and Education Office
... prescribed, observing rules above. Patients on long/short acting Insulin: The evening prior to the ... examination you should inject the prescribed long acting Insulin dose. In the morning of the examination take ... prescribed, observing rules above. Patients on long/short acting Insulin: The evening prior to the ... examination you should inject the prescribed long acting Insulin dose. In the morning of the examination take ...
... prescribed, observing rules above. Patients on long/short acting Insulin: The evening prior to the ... examination you should inject the prescribed long acting Insulin dose. In the morning of the examination take ... prescribed, observing rules above. Patients on long/short acting Insulin: The evening prior to the ... examination you should inject the prescribed long acting Insulin dose. In the morning of the examination take ...
ETH Entrepreneurship
https://ethz.ch/en/industry/entrepreneurship.html
8952 Schlieren, Wagistrasse 18
Excellence in entrepreneurship at ETH Zurich is driven by world-class research and education. It gives rise to groundbreaking new ventures that consolidate Switzerland’s technological leadership. Are you an aspiring entrepreneur seeking to find solutions to global challenges and create a better future for humanity. Or are you just interested in the entrepreneurial ecosystem at ETH Zurich? Browse our websites to find out more or reach out to the Entrepreneurship group, if you have any questions.
ETH Entrepreneurship
Wagistrasse 18
8952 Schlieren
859 Ergebnisse für "acting" unter ETH Entrepreneurship
... share a passion for acting. For almost 20 years, mostly ETH and Uni students are meeting in the Aki once ... founded by and for active young people who share a passion for acting. For almost 20 years, mostly ETH and ...
Patents – Sensory-Motor Systems Lab | ETH Zurich
... distance, from the second transmittal system acting on the object, wherein said influencer information is ... transmittal system acting on the object, wherein said influencer information is transmitted via a signal line ...
Molecular Partners AG
http://www.molecularpartners.com
8952 Schlieren, Wagistrasse 14
+41 44 755 77 00
Molecular Partners AG is a clinical-stage biopharmaceutical company, located in Schlieren, Switzerland, that is developing a new class of therapies known as DARPin® therapies.
Molecular Partners AG
Wagistrasse 14
8952 Schlieren
20 Ergebnisse für "acting" unter Molecular Partners AG
IPO successfully priced post re-launch - Molecular Partners
... shares, respectively. J.P. Morgan is acting as the Sole Global Coordinator and Joint Bookrunner and UBS ... Investment Bank is acting as Joint Bookrunner. Cowen and Company and Bank am Bellevue are acting as Co ... -allotment option of up to 660,000 newly-issued registered shares, respectively. J.P. Morgan is acting as the ... Sole Global Coordinator and Joint Bookrunner and UBS Investment Bank is acting as Joint Bookrunner ...
Molecular Partners announces publication of its clinical phase I/II...
... evaluating the safety and preliminary activity of MP0112, a long- acting anti-VEGF DARPin, in patients with ... - acting anti-VEGF DARPin, in patients with Diabetic Macular Edema (DME) have been published on-line in The ...
Bio-Technopark Schlieren-Zürich
8952 Schlieren, Wagistrasse 23
+41 76 336 99 44
mario.jenni@bio-technopark.ch
The Bio-Technopark offers professional support for life science start-ups in the setting up and expansion of business activities and promotes interaction between start-ups, academia and industry. A nationally and internationally respected science park has grown up at Schlieren. Through stringent selection, coaching and support, more than 30 successful start-up companies with 750 employees are located here. Eight have been acquired by large corporates, but are still active in the park. Together with 20 institutes and clinics from the University and University Hospital Zurich, an innovative mix of very young and well-established companies and academic research groups has emerged.
Bio-Technopark Schlieren-Zürich
Wagistrasse 23
8952 Schlieren
5 Ergebnisse für "acting" unter Bio-Technopark Schlieren-Zürich
Patrick Amstutz Appointed as Chief Executive Officer › BIO-TECHNOPA...
... Directors appointed Patrick Amstutz as acting CEO, and engaged in a process to find the best suitable ... Amstutz as acting CEO, and engaged in a process to find the best suitable internal or external candidate ...
Molecular Partners Announces Pricing of Initial Public Offering of ...
... June 18, 2021, subject to customary closing conditions. J.P. Morgan, SVB Leerink and Cowen are acting ... as joint book-running managers for the proposed offering. RBC Capital Markets is acting as the ... closing conditions. J.P. Morgan, SVB Leerink and Cowen are acting as joint book-running managers for the ... proposed offering. RBC Capital Markets is acting as the bookrunner for the proposed offering. Kempen & Co ...
Neurimmune Therapeutics AG
8952 Schlieren, Wagistrasse 18
+41 44 755 46 46
info@neurimmune.com
Neurimmune is a biopharmaceutical company dedicated to the development of immunotherapeutics for the treatment and prevention of human disorders with a focus on protein aggregation diseases.
Neurimmune Therapeutics AG
Wagistrasse 18
8952 Schlieren
2 Ergebnisse für "acting" unter Neurimmune Therapeutics AG
Neurimmune - Type-2 Diabetes
... intervention acting on different pathways to decrease blood glucose levels by either improving insulin ... treatments include dietary management and pharmacological intervention acting on different pathways to ...
Code of Conduct – Neurimmune
... an honest and ethical manner. To fulfill that commitment, each of us is responsible for acting with ... conduct business (consultants, vendors and any other third party acting under their control on behalf of ... . To fulfill that commitment, each of us is responsible for acting with integrity every day. The Code ... , vendors and any other third party acting under their control on behalf of the Company, referred to in this ...
Kuros Biosciences AG
8952 Schlieren, Wagistrasse 25
+41 (0)44 733 4747
Our focus is on revolutionizing the field of orthobiologics by developing bone grafts that deliver both targeted and controlled bone healing.
Kuros Biosciences AG
Wagistrasse 25
8952 Schlieren
6 Ergebnisse für "acting" unter Kuros Biosciences AG
Kuros Biosciences MagnetOs RCT FPI
... . Prior to that he was acting as Chief Accounting Officer and Vice President of Finance at the ... investor relations, and before that he was acting as a CFO for EMEA and Vice President of Finance at ... . Prior to that he was acting as Chief Accounting Officer and Vice President of Finance at the ... investor relations, and before that he was acting as a CFO for EMEA and Vice President of Finance at ...
Kuros Biosciences Announces Changes to Executive Management Team - ...
... capital markets consulting services. Prior to that he was acting as Chief Accounting Officer and Vice ... corporate accounting, controlling and investor relations, and before that he was acting as a CFO for EMEA ... acting as Chief Accounting Officer and Vice President of Finance at the biopharmaceutical company Autolus ... before that he was acting as a CFO for EMEA and Vice President of Finance at software developer Kofax. He ...
Roche Glycart AG
https://www.roche.ch/en/sites/schlieren
8952 Schlieren, Wagistrasse 10
+41 43 215 10 00
The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.
Roche Glycart AG
Wagistrasse 10
8952 Schlieren
100 Ergebnisse für "acting" unter Roche Glycart AG
Roche Group Code of Conduct - Code of Conduct
... employees and all others acting on behalf of Roche must comply and make judgments in accordance with the ... acting on behalf of Roche must comply with the Roche Group Code of Conduct, regardless of their location ... implement the Roche Group Code of Conduct locally. All employees and all others acting on behalf of Roche ... Conduct apply to everyone in the Roche Group? Yes. All employees and all others acting on behalf of Roche ...
Addressing Non-compliance - Code of Conduct
... that the Line Manager has insisted on my acting accordingly? No. If your Line Manager is insisting on ... note stating that the Line Manager has insisted on my acting accordingly? No. If your Line Manager is ...
